Breast cancer is a complex heterogeneous disease, with each subtype characterized by distinct clinical features and molecular alterations. The heterogeneity of breast cancer has presented massive challenges for identifying appropriate treatment for each patient. Advances in next-generation sequencing (NGS) have presented unique treatment opportunities beyond stratification of patients by hormone receptor and epidermal growth factor receptor status. QIAGEN® Clinical Insight (QCI™ Interpret) is a web-based application for the annotation, classification, and reporting of actionable variants from NGS data in clinical genomics laboratories.

Learning Objectives: 

• Understand how QCI Interpret identifies molecular alterations that have direct treatment implications for patients, based on five real world clinical cases from TCGA.
• Discover how the richness of the QIAGEN Knowledge Base and the versatility of QCI Interpret contribute to  presenting treatment options for patients.